// App-Quantinova.ai

TCT-311 : 4-Year Clinical Outcomes in High Bleeding Risk Patients After Surgical or Percutaneous Left Main Coronary Artery Revascularization: The EXCEL Trial

Researchers

Presenter

  • Bimmer Claessen

Principal Investigators

  • Gennaro Giustino

  • Ori Ben-Yehuda

  • David Taggart

  • David Kandzari

  • Marie-Claude Morice

  • Roxana Mehran

  • Annapoorna Kini

  • Paul Guedeney

  • A. Pieter Kappetein

  • Joseph Sabik

  • Patrick Serruys

  • Gregg Stone

Medical Centers

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • Cardiovascular Research Foundation, Columbia University Medical Center/New York–Presbyterian Hospital, New York, New York

  • Piedmont Heart Institute, Atlanta, Georgia

  • Icahn School of Medicine at Mount Sinai, New York, New York, USA

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio

  • Mount Sinai Hospital, New York, New York

  • Oxford University, Oxford, United Kingdom

  • Imperial College, London, United Kingdom

  • The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital, New York, NY

  • CERC, Massy, France

Locations

  • Netherlands

  • United States

  • United Kingdom

  • France

  • Georgia

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Left main disease

  • Thrombocytopenia

  • Anemia

  • Stroke

Biomarkers

  • Creatinine

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved